Lucentis 0.5 mg/0.05 mL (10 mg/mL) injection Images
Generic Name: ranibizumab
This medication has been identified as Lucentis 0.5 mg/0.05 mL (10 mg/mL) injection. It is supplied by Genentech, Inc.
Lucentis is used in the treatment of Macular Degeneration; Diabetic Retinopathy; Myopic Choroidal Neovascularization; Diabetic Macular Edema; Macular Edema and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Lucentis 0.5 mg/0.05 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Lucentis
- Generic Name
- ranibizumab
- Strength
- 0.5 mg/0.05 mL (10 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0080
See also:
Syfovre
Syfovre (pegcetacoplan) treatment for geographic atrophy (GA) a form of dry age-related macular ...
Eylea
Eylea is used to treat neovascular (wet) age-related macular degeneration (AMD), macular edema ...
Izervay
Izervay (avacincaptad pegol) is used for treating geographic atrophy (GA) due to age-related ...
Vabysmo
Vabysmo eye injection is used to treat eye diseases neovascular (wet) age-related macular ...
Pavblu
Pavblu (aflibercept-ayyh) is a biosimilar to Eylea that may be used to treat the following eye ...
Byooviz
Byooviz injection is used to treat types of macular degeneration, macular edema and mCNV. Byooviz ...
Eylea HD
Eylea HD is used to treat neovascular (wet) age-related macular degeneration (AMD), diabetic ...
Beovu
Beovu (brolucizumab-dbll) injection is a biological drug that is used to treat two chronic eye ...
Pegcetacoplan ophthalmic
Pegcetacoplan eye injections (Syfovre) are used to treat geographic atrophy (GA), the dry, advanced ...
More about Lucentis (ranibizumab ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (15)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.